Professor of Cardiometabolic Medicine/Honorary Consultant, University of Glasgow
Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on markers of cardiovascular and metabolic health, such as high cholesterol and high blood pressure, according to a meta-analysis published by The BMJ. The research includes 37 studies published up to February 2025 involving more than 9,300 people.
People who ate more than 50 grams of high-fat cheese—such as cheddar, brie, or gouda—per day in the 1990s had a lower risk of dementia 25 years later than those who consumed less cheese, according to a study published in Neurology. The study is based on data from more than 27,000 people in Sweden with an average age of 58. The research also shows that those who consumed high-fat cream daily had a lower risk of dementia compared to those who did not consume it.
Intermittent fasting has similar effects to calorie-restricted diets in terms of weight loss, concludes a meta-analysis, published in The BMJ, pooling the results of 99 previous clinical trials. Of three types of intermittent fasting (alternate-day fasting, time-restricted eating and all-day fasting), intermittent fasting has a higher impact on weight reduction compared to continuous energy restriction, the study adds.
In a group of people at high cardiovascular risk, low to moderate wine consumption was associated with fewer cardiovascular events (cardiovascular death, myocardial infarction, stroke or heart failure), according to a study. The analysis uses urinary concentrations of tartaric acid, a substance found in grapes and grape derivatives, as a biomarker of wine consumption. It finds that consuming between three and 35 glasses per month was associated with fewer cardiovascular events than in people who consumed fewer than three or more than 35 glasses. The study, published in the European Heart Journal, included more than 1,200 participants from Spain's PREDIMED study with an average age of 68 years.